Cyberattack Halts Order Fulfillment at Boston Scientific, Shares Slide 4.2%
BSX sits 18% above its 52-week low of $42.2.
Summary
Boston Scientific disclosed a cyberattack that has caused a global outage of key operational technology, leaving the company unable to fill orders. The company, which reported $20 billion in revenue in 2025, said it doesn't know when systems will be restored. Shares fell nearly 4.2% in early trading Wednesday to $47.78. This follows the 8-K filed this morning and the earlier Dow Jones report, but adds the market's reaction and the uncertainty around restoration timing. The outage compounds recent setbacks: last month the company cut full-year guidance after product issues, and it is in the midst of a $700M–$800M restructuring with layoffs. The inability to process orders could materially impact near-term revenue, especially given the company's scale.
At the time of this announcement, BSX was trading at $49.91 on NYSE in the Life Sciences sector, with a market capitalization of approximately $72.3B. The 52-week trading range was $42.20 to $109.50. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.